Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A virus-induced molecular mimicry model of multiple sclerosis
Julie K. Olson, … , Mauro C. Dal Canto, Stephen D. Miller
Julie K. Olson, … , Mauro C. Dal Canto, Stephen D. Miller
Published July 15, 2001
Citation Information: J Clin Invest. 2001;108(2):311-318. https://doi.org/10.1172/JCI13032.
View: Text | PDF
Article Article has an altmetric score of 16

A virus-induced molecular mimicry model of multiple sclerosis

  • Text
  • PDF
Abstract

Molecular mimicry is the process by which virus infection activates T cells that are cross-reactive with self antigens. Infection of SJL/J mice with the neurotropic picornavirus Theiler’s murine encephalomyelitis virus (TMEV) leads to a progressive CD4+ T cell–mediated demyelinating disease similar to multiple sclerosis. To study the potential of virus-induced molecular mimicry to initiate autoimmune demyelination, a nonpathogenic TMEV variant was engineered to encode a 30-mer peptide encompassing the immunodominant encephalitogenic myelin proteolipid protein (PLP139-151) epitope. Infection with the PLP139-151–encoding TMEV led within 10–14 days to a rapid-onset paralytic demyelinating disease characterized by PLP139-151–specific CD4+ Th1 responses; insertion of a non-self ovalbumin sequence led to restoration of the normal late-onset disease. Early-onset disease was also observed in mice infected with a TMEV encoding PLP139-151 with an amino acid substitution at the secondary T cell receptor (TCR) contact residue (H147A), but not in mice infected with TMEV encoding a PLP139-151 substitution at the primary TCR contact (W144A). Most significantly, mice infected with TMEV encoding a Haemophilus influenzae mimic peptide, sharing only 6 of 13 amino acids with PLP139-151, displayed rapid-onset disease and developed cross-reactive PLP139-151–specific CD4+ Th1 responses. To our knowledge, this is the first study showing that a naturally infectious virus encoding a myelin epitope mimic can directly initiate organ-specific T cell–mediated autoimmunity.

Authors

Julie K. Olson, J. Ludovic Croxford, Miriam. A. Calenoff, Mauro C. Dal Canto, Stephen D. Miller

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
SJL mice infected with TMEV containing the native PLP139-151 sequence de...
SJL mice infected with TMEV containing the native PLP139-151 sequence develop early myelin-specific CD4+ T cell responses. SJL mice were infected with PLP139-BeAn, wild-type BeAn, OVA323-BeAn, or ΔClaI-BeAn. (a) At 14 days PI, the mice were ear-challenged with 5 μg PLP139-151 or TMEV VP2 70-86 and in vivo DTH responses were determined 24 hours after challenge. **DTH responses significantly higher than those in mock infected controls; P ≤ 0.01. Splenic CD4+ T cell proliferative responses from 2–3 mice per group were determined at 14 days (b), 28 days (c), and 90 days PI (d) to the immunodominant TMEV epitope, VP2 70-86, and to a panel of myelin epitopes — PLP139-151, PLP56-70, and PLP178-191. T cell proliferation was determined at 96 hours and results expressed as mean cpm ± SEM of triplicate cultures. *Stimulation index (cpm + antigen)/(cpm – antigen) ≥ 3. Results are representative of three separate experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 1
Referenced in 5 Wikipedia pages
55 readers on Mendeley
See more details